文献速递产科母胎医学

钙补充预防子痫前期:系统评价与网络Meta分析以指导个体化产前保健

Calcium for pre-eclampsia prevention: A systematic review and network meta-analysis to guide personalised antenatal care.
PubMed 文献 · BJOG · 2022-06-28

该系统评价与网络Meta分析纳入30项试验(N=20445名女性)评估钙补充预防子痫前期,高剂量(≥1g/日)与低剂量(<1g/日)均有效(RR分别为0.49),网络Meta分析纳入25项试验(N=15038)显示高剂量与低剂量无差异(RR 0.79,95%CI 0.43-1.40);基线钙摄入充足女性中钙补充无效。

要点

  • 高剂量(≥1g/日)钙补充预防子痫前期RR 0.49(95%CI 0.36-0.66),低剂量(<1g/日)RR 0.49(95%CI 0.36-0.65)。
  • 网络Meta分析显示高剂量与低剂量钙补充效果无差异(RR 0.79,95%CI 0.43-1.40)。
  • 基线平均钙摄入充足的女性中钙补充无效。

核心结论

  • 低剂量和高剂量钙补充对低钙摄入女性预防子痫前期均有效,这对膳食钙低地区的人群实施和钙摄入充足地区的针对性实施有启示。

研究设计与样本

  • 系统评价与网络Meta分析,检索CENTRAL、PubMed、Global Index Med、CINAHL等数据库从建库至2021年2月2日,纳入随机对照试验;Meta分析纳入30项试验(N=20445名女性),网络Meta分析评估钙剂量纳入25项试验(N=15038名女性)。

主要发现

  • 钙补充预防子痫前期高剂量组RR 0.49(95%CI 0.36-0.66),低剂量组RR 0.49(95%CI 0.36-0.65)。
  • 网络Meta分析显示高剂量对比低剂量钙补充效果无差异(RR 0.79,95%CI 0.43-1.40)。
  • 无论基线子痫前期风险、维生素D联合补充或钙启动时机如何,钙补充效果相似,但基线平均钙摄入充足的女性中钙补充无效。

临床怎么用

  • 低钙摄入女性可考虑低剂量或高剂量钙补充以预防子痫前期;膳食钙低的地区可考虑人群层面实施,平均摄入充足的地区可考虑针对性实施。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Calcium supplementation reduces the risk of pre-eclampsia, but questions remain about the dosage to prescribe and who would benefit most. OBJECTIVES: To evaluate the effectiveness of high (≥1 g/day) and low (<1 g/day) calcium dosing for pre-eclampsia prevention, according to baseline dietary calcium, pre-eclampsia risk and co-interventions, and intervention timing. SEARCH STRATEGY: CENTRAL, PubMed, Global Index Medicus and CINAHL, from inception to 2 February 2021, clinical trial registries, reference lists and expert input (CRD42018111239). SELECTION CRITERIA: Randomised controlled trials of calcium supplementation for pre-eclampsia prevention, for women before or during pregnancy. Network meta-analysis (NMA) also included trials of different calcium doses. DATA COLLECTION AND ANALYSIS: Two independent reviewers extracted published data. The meta-analysis employed random-effects models and the NMA, a Bayesian random-effects model, to obtain direct and indirect effect estimates. MAIN RESULTS: The meta-analysis included 30 trials (N = 20 445 women), and the NMA to evaluate calcium dosage included 25 trials (N = 15 038). Calcium supplementation prevented pre-eclampsia similarly with a high dose (RR 0.49, 95% CI 0.36-0.66) or a low dose (RR 0.49, 95% CI 0.36-0.65). By NMA, high-dose (vs low-dose) calcium did not differ in effect (RR 0.79, 95% CI 0.43-1.40). Calcium was similarly effective regardless of baseline pre-eclampsia risk, vitamin D co-administration or timing of calcium initiation, but calcium was ineffective among women with adequate average baseline calcium intake. CONCLUSIONS: Low- and high-dose calcium supplementation are effective for pre-eclampsia prevention in women with low calcium intake. This has implications for population-level implementation where dietary calcium is low, and targeted implementation where average intake is adequate. TWEETABLE ABSTRACT: A network meta-analysis of 25 trials found that low-dose calcium supplementation (<1 g/day) is as effective as high-dose calcium supplementation (≥1 g/day) in halving the risk of pre-eclampsia when baseline calcium intake is low.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Woo Kinshella ML, Sarr C, Sandhu A, et al. Calcium for pre-eclampsia prevention: A systematic review and network meta-analysis to guide personalised antenatal care. BJOG. 2022. PMID: 35596262. doi:10.1111/1471-0528.17222

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。